CLESROVIMAB

13 reported adverse events

Drug classes: Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]

CLESROVIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BACTERIAL TEST POSITIVE 1 0.0004
1 BLOOD CULTURE POSITIVE 1 0.0003
2 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
3 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
4 EXTRA DOSE ADMINISTERED 2 0.0000
5 NO ADVERSE EVENT 5 0.0000
6 INJECTION SITE MASS 1 0.0000
7 INJECTION SITE SWELLING 2 0.0000
8 MEDICATION ERROR 1 0.0000
9 INFLUENZA 1 0.0000
See all enriched reactions for CLESROVIMAB